Clinical Study

Prevalence and Risk Factors of Prostate Cancer in Chinese Men with PSA 4–10 ng/mL Who Underwent TRUS-Guided Prostate Biopsy: The Utilization of PAMD Score

Table 3

Biopsy outcomes between different risk groups stratified by PAMD score.

PAMD scoreALLPCaHGPCa
NoYesChi-squareNoYesChi-square

Low0-16561 (93.8)4 (6.2)91.187< 63 (96.9)2 (3.1)85.457<
Intermediate2-312997 (75.2)32 (24.8)113 (87.6)16 (12.4%)
HighOver 415149 (32.4)102 (67.6)69 (45.7)82 (54.3)

Statistically significant.
PAMD = prostate volume + age + magnetic resonance imaging + digital rectal examination; PCa = prostate cancer; HGPCa = high grade prostate cancer.